Proliposomal testosterone formulations

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 8957053
APP PUB NO 20140112986A1
SERIAL NO

14149227

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Novel testosterone formulations are disclosed where testosterone is incorporated into a phospholipid/cholesterol system to produce a proliposomal powder dispersion. The proliposomal powder dispersions of the invention may be formulated with pharmaceutically acceptable excipients to form pharmaceutical compositions. Enterically coated oral dosage forms are disclosed as are methods of treatment for testosterone replacement therapy.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

  • WESTERN UNIVERSITY OF HEALTH SCIENCES;TESORX PHARMA, LLC

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Betageri, Guru V Chino Hills, US 25 73
Kadajji, Veeran Gowda North Hollywood, US 7 10
Thirucote, Ramachandran Atherton, US 21 44

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Aug 17, 2026
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00